Show simple item record

dc.contributor.authorLitchfield, Ken_US
dc.contributor.authorTurajlic, Sen_US
dc.contributor.authorSwanton, Cen_US
dc.coverage.spatialUnited Statesen_US
dc.date.accessioned2018-03-05T12:49:39Z
dc.date.issued2017-08en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/28765114en_US
dc.identifier7/8/796en_US
dc.identifier.citationCancer Discov, 2017, 7 (8), pp. 796 - 798en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1539
dc.identifier.eissn2159-8290en_US
dc.identifier.doi10.1158/2159-8290.CD-17-0604en_US
dc.description.abstract<b/> In this issue of Cancer Discovery, an overview of the AACR Project GENIE, a landmark study in cancer genomics, is presented by The AACR Project GENIE Consortium. A summary of the goals and objectives of this ambitious program is provided, together with an analysis of the phase I cohort of 19,000 samples. Cancer Discov; 7(8); 796-8. ©2017 AACR.See related article by The AACR Project GENIE Consortium, p. 818.en_US
dc.format.extent796 - 798en_US
dc.languageengen_US
dc.language.isoengen_US
dc.subjectBiomarkers, Pharmacologicalen_US
dc.subjectBiomarkers, Tumoren_US
dc.subjectGene Expression Regulation, Neoplasticen_US
dc.subjectGenomicsen_US
dc.subjectHumansen_US
dc.subjectNeoplasmsen_US
dc.titleThe GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released.en_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1158/2159-8290.CD-17-0604en_US
rioxxterms.licenseref.startdate2017-08en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfCancer Discoven_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume7en_US
pubs.embargo.termsNot knownen_US
dc.contributor.icrauthorMarsden,en_US
dc.contributor.icrauthorTurajlic, Samraen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record